Kraken, OK Group, 9fBank and Baofoo are in line to exit Wyre, with its cryptocurrency infrastructure technology to strengthen Bolt's one-click checkout offering.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.

The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

Crypto.com, Huobi and BitMart invested in cryptocurrency scaling technology developer Boba Network at a $1.5bn valuation while natural fibre composite provider Bcomp netted $34.9m in a BMW-led round.

HPE, Alphabet, Ericsson, Qualcomm, Oracle, Liberty Global and NetApp are set to exit the edge computing technology provider.

The Macrogen-backed gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

Fertility financing service Future Family, machine learning software developer Black Crow AI and digital twin software provider vHive each nabbed $25m in corporate-backed rounds.

The China Resources and Legend Holdings-backed vaccine technology developer floated in Hong Kong in a $97.7m offering following nearly $460m in funding.

BitFlyer shareholders including Sekisui House have reportedly negotiated a majority sale of the cryptocurrency exchange for up to $370m.